Disruption of follicular dendritic cells-follicular lymphoma cross-talk by the pan-PI3K inhibitor BKM120 (Buparlisib).
about
Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances.Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma.A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.The role of G protein-coupled receptors in lymphoid malignancies.
P2860
Disruption of follicular dendritic cells-follicular lymphoma cross-talk by the pan-PI3K inhibitor BKM120 (Buparlisib).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Disruption of follicular dendr ...... inhibitor BKM120 (Buparlisib).
@en
type
label
Disruption of follicular dendr ...... inhibitor BKM120 (Buparlisib).
@en
prefLabel
Disruption of follicular dendr ...... inhibitor BKM120 (Buparlisib).
@en
P2093
P50
P1476
Disruption of follicular dendr ...... inhibitor BKM120 (Buparlisib).
@en
P2093
Alba Matas-Céspedes
Anna Vidal-Crespo
Armando López-Guillermo
Laia Rosich
Neus Villamor
Patricia Balsas
Patricia Pérez-Galán
Teresa Casserras
Vanina Rodriguez
P304
P356
10.1158/1078-0432.CCR-14-0154
P407
P577
2014-05-05T00:00:00Z